Results
|
|
9581.
|
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience. [electronic resource] by
- Lobe, I
- Rigal-Huguet, F
- Vekhoff, A
- Desablens, B
- Bordessoule, D
- Mounier, C
- Ferrant, A
- Sanz, M
- Fey, M
- Chomienne, C
- Chevret, S
- Degos, L
- Fenaux, P
Producer: 20031106
In:
Leukemia vol. 17
Availability: No items available.
|
|
|
9582.
|
|
|
|
9583.
|
Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells. [electronic resource] by
- Horvath, Z
- Saiko, P
- Illmer, C
- Madlener, S
- Hoechtl, T
- Bauer, W
- Erker, T
- Jaeger, W
- Fritzer-Szekeres, M
- Szekeres, T
Producer: 20070123
In:
Nucleosides, nucleotides & nucleic acids vol. 25
Availability: No items available.
|
|
|
9584.
|
|
|
|
9585.
|
|
|
|
9586.
|
Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. [electronic resource] by
- Pereira, Juliana
- Bellesso, Marcelo
- Pracchia, Luis Fernando
- Neto, Abrahão Elias Hallack
- Beitler, Beatriz
- de Almeida Macedo, Maria Cristina Martins
- Dias, Lucia Cristina Santos
- Dorlhiac-Llacer, Pedro Enrique
- Dulley, Frederico Luiz
- Chamone, Dalton
Producer: 20060608
In:
Leukemia research vol. 30
Availability: No items available.
|
|
|
9587.
|
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen. [electronic resource] by
- Moreton, P
- Morgan, G J
- Gilson, D
- Smith, G M
- McVerry, B A
- Davies, J M
- Mackie, M J
- Bolam, S
- Jalihal, S S
- Howard, M R
- Parapia, L A
- Williams, A T
- Child, J A
Producer: 20040503
In:
Cancer chemotherapy and pharmacology vol. 53
Availability: No items available.
|
|
|
9588.
|
Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome. [electronic resource] by
- Suzuki, Keijiro
- Sugawara, Takeshi
- Oyake, Tatsuo
- Uchiyama, Toshiyuki
- Aoki, Yusei
- Tsukushi, Yasuhiko
- Onodera, Shima
- Ito, Shigeki
- Murai, Kazunori
- Ishida, Yoji
Producer: 20071127
In:
Leukemia research vol. 31
Availability: No items available.
|
|
|
9589.
|
|
|
|
9590.
|
|
|
|
9591.
|
|
|
|
9592.
|
|
|
|
9593.
|
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia. [electronic resource] by
- Klisovic, Rebecca B
- Blum, William
- Wei, Xiaohui
- Liu, Shujun
- Liu, Zhongfa
- Xie, Zhiliang
- Vukosavljevic, Tamara
- Kefauver, Cheryl
- Huynh, Lenguyen
- Pang, Jiuxia
- Zwiebel, James A
- Devine, Steven
- Byrd, John C
- Grever, Michael R
- Chan, Kenneth
- Marcucci, Guido
Producer: 20080925
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 14
Availability: No items available.
|
|
|
9594.
|
|
|
|
9595.
|
Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients. [electronic resource] by
- Faderl, Stefan
- Ravandi, Farhad
- Huang, Xuelin
- Wang, Xuemei
- Jabbour, Elias
- Garcia-Manero, Guillermo
- Kadia, Tapan
- Ferrajoli, Alessandra
- Konopleva, Marina
- Borthakur, Gautam
- Burger, Jan
- Feliu, Jennie
- Kantarjian, Hagop M
Producer: 20121119
In:
Cancer vol. 118
Availability: No items available.
|
|
|
9596.
|
A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma. [electronic resource] by
- Kurita, Naoki
- Nishikii, Hidekazu
- Nakamoto, Rie
- Nakamura, Naoya
- Kondo, Yuzuru
- Okoshi, Yasushi
- Suzukawa, Kazumi
- Hasegawa, Yuichi
- Yokoyama, Yasuhisa
- Noguchi, Masayuki
- Chiba, Shigeru
Producer: 20111013
In:
Journal of clinical and experimental hematopathology : JCEH vol. 51
Availability: No items available.
|
|
|
9597.
|
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study. [electronic resource] by
- Schaich, Markus
- Röllig, Christoph
- Soucek, Silke
- Kramer, Michael
- Thiede, Christian
- Mohr, Brigitte
- Oelschlaegel, Uta
- Schmitz, Norbert
- Stuhlmann, Reingard
- Wandt, Hannes
- Schäfer-Eckart, Kerstin
- Aulitzky, Walter
- Kaufmann, Martin
- Bodenstein, Heinrich
- Tischler, Joachim
- Ho, Anthony
- Krämer, Alwin
- Bornhäuser, Martin
- Schetelig, Johannes
- Ehninger, Gerhard
Producer: 20110906
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29
Availability: No items available.
|
|
|
9598.
|
|
|
|
9599.
|
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: results from the LRF AML14 and NCRI AML16 pick-a-winner comparison. [electronic resource] by
- Burnett, A K
- Hills, R K
- Hunter, A E
- Milligan, D
- Kell, W J
- Wheatley, K
- Yin, J
- McMullin, M F
- Dignum, H
- Bowen, D
- Russell, N H
Producer: 20130228
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
9600.
|
|